MicroRNAs prevent the generation of autoreactive antibodies

Immunity

Volumn 33, Issue 5, 2010, Pages 713-722

  Belver, Laura ^a   de Yébenes, Virginia G ^a   Ramiro, Almudena R ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BRUTON TYROSINE KINASE; CD19 ANTIBODY; IMMUNOGLOBULIN; MICRORNA; MICRORNA 185; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD19; AUTOANTIBODIES; B-LYMPHOCYTES; CELL DIFFERENTIATION; DEAD-BOX RNA HELICASES; DOWN-REGULATION; ENDORIBONUCLEASES; FEMALE; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MICRORNAS; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, B-CELL;

EID: 78650196925     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2010.11.010     Document Type: Article

References (39)

1. Allman D., Pillai S. Peripheral B cell subsets. Curr. Opin. Immunol. 2008, 20:149-157.
2. Bassing C.H., Swat W., Alt F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002, 109(Suppl):S45-S55.
3. Carsetti R., Rosado M.M., Wardmann H. Peripheral development of B cells in mouse and man. Immunol. Rev. 2004, 197:179-191.
4. Crouzier R., Martin T., Pasquali J.L. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors. J. Immunol. 1995, 154:4526-4535.
5. Dammers P.M., Visser A., Popa E.R., Nieuwenhuis P., Kroese F.G. Most marginal zone B cells in rat express germline encoded Ig VH genes and are ligand selected. J. Immunol. 2000, 165:6156-6169.
6. de Yébenes V.G., Belver L., Pisano D.G., González S., Villasante A., Croce C., He L., Ramiro A.R. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 2008, 205:2199-2206.
7. Dingjan G.M., Maas A., Nawijn M.C., Smit L., Voerman J.S., Grosveld F., Hendriks R.W. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase. EMBO J. 1998, 17:5309-5320.
8. Goodnow C.C., Crosbie J., Adelstein S., Lavoie T.B., Smith-Gill S.J., Brink R.A., Pritchard-Briscoe H., Wotherspoon J.S., Loblay R.H., Raphael K., et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988, 334:676-682.
9. Grimaldi C.M., Hicks R., Diamond B. B cell selection and susceptibility to autoimmunity. J. Immunol. 2005, 174:1775-1781.
10. Gu H., Tarlinton D., Müller W., Rajewsky K., Förster I. Most peripheral B cells in mice are ligand selected. J. Exp. Med. 1991, 173:1357-1371.
11. Halcomb K.E., Musuka S., Gutierrez T., Wright H.L., Satterthwaite A.B. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells. Mol. Immunol. 2008, 46:233-241.
12. Harfe B.D., McManus M.T., Mansfield J.H., Hornstein E., Tabin C.J. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc. Natl. Acad. Sci. USA 2005, 102:10898-10903.
13. Hartley S.B., Crosbie J., Brink R., Kantor A.B., Basten A., Goodnow C.C. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991, 353:765-769.
14. Hayakawa K., Hardy R.R., Honda M., Herzenberg L.A., Steinberg A.D., Herzenberg L.A. Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl. Acad. Sci. USA 1984, 81:2494-2498.
15. Hobeika E., Thiemann S., Storch B., Jumaa H., Nielsen P.J., Pelanda R., Reth M. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA 2006, 103:13789-13794.
16. Ichiyoshi Y., Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J. Exp. Med. 1994, 180:885-895.
17. Khan W.N., Alt F.W., Gerstein R.M., Malynn B.A., Larsson I., Rathbun G., Davidson L., Müller S., Kantor A.B., Herzenberg L.A., et al. Defective B cell development and function in Btk-deficient mice. Immunity 1995, 3:283-299.
18. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009, 10:126-139.
19. Koralov S.B., Muljo S.A., Galler G.R., Krek A., Chakraborty T., Kanellopoulou C., Jensen K., Cobb B.S., Merkenschlager M., Rajewsky N., Rajewsky K. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008, 132:860-874.
20. Li Y., Li H., Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 2002, 195:181-188.
21. Maas A., Dingjan G.M., Grosveld F., Hendriks R.W. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region. J. Immunol. 1999, 162:6526-6533.
22. Martin F., Kearney J.F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000, 12:39-49.
23. Martin F., Kearney J.F. Marginal-zone B cells. Nat. Rev. Immunol. 2002, 2:323-335.
24. Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001, 14:617-629.
25. Martinez J., Busslinger M. Life beyond cleavage: The case of Ago2 and hematopoiesis. Genes Dev. 2007, 21:1983-1988.
26. Meffre E., Wardemann H. B-cell tolerance checkpoints in health and autoimmunity. Curr. Opin. Immunol. 2008, 20:632-638.
27. Meffre E., Casellas R., Nussenzweig M.C. Antibody regulation of B cell development. Nat. Immunol. 2000, 1:379-385.
28. Nemazee D.A., Bürki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989, 337:562-566.
29. Ng Y.S., Wardemann H., Chelnis J., Cunningham-Rundles C., Meffre E. Bruton's tyrosine kinase is essential for human B cell tolerance. J. Exp. Med. 2004, 200:927-934.
30. Pillai S., Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 2009, 9:767-777.
31. Rickert R.C., Roes J., Rajewsky K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 1997, 25:1317-1318.
32. Satterthwaite A.B., Cheroutre H., Khan W.N., Sideras P., Witte O.N. Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Proc. Natl. Acad. Sci. USA 1997, 94:13152-13157.
33. Schmidt-Supprian M., Rajewsky K. Vagaries of conditional gene targeting. Nat. Immunol. 2007, 8:665-668.
34. Shlomchik M.J. Sites and stages of autoreactive B cell activation and regulation. Immunity 2008, 28:18-28.
35. Su T.T., Guo B., Wei B., Braun J., Rawlings D.J. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol. Rev. 2004, 197:161-178.
36. Wardemann H., Nussenzweig M.C. B-cell self-tolerance in humans. Adv. Immunol. 2007, 95:83-110.
37. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science 2003, 301:1374-1377.
38. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2001, 2:777-780.
39. Xiao C., Rajewsky K. MicroRNA control in the immune system: Basic principles. Cell 2009, 136:26-36.